Objective: A study was undertaken to test the psychometric properties of the Fatigue Severity Scale (FSS), and to explore the relationship between fatigue and sociodemographic variables in the general population. Method: A national representative sample of 1893 respondents was randomly selected from a pool of 4,000 Norwegians aged 19—81 years. A mailed questionnaire that included the FSS was used to measure fatigue severity. Results: The FSS showed satisfactory internal consistency (Cronbach's alpha 0.88). The prevalence of high fatigue (FSS score>=5) was 23.1% in the total sample. More women (26.2%) than men (19.8%) experienced high fatigue (p=0.004). Respondents with chronic illness (more than six months) reported a higher mean (M=4.69, SD=1.35) than the rest of the sample (M=3.67, SD=1.17) (p<0.001). An inverse correlation was found between fatigue and level of formal education (r=0.20, p<0.001). Conclusion: The psychometric properties of the Norwegian version of FSS were satisfactory. To avoid over-diagnosing people for high level of fatigue, the threshold for high fatigue probably should be 5 on the FSS scale instead of 4 as had been suggested originally, but further validation of the cut-off point is needed.
Loge JH, Ekeberg O., Kaasa S.Fatigue in the general Norwegian population: normative data and associations . J Psychosom Res1998;45:Spec No: 53—65.
2.
Lerdal A.A theoretical extension of the concept of energy through an empirical study . Scand J Caring Sci2002; 16:197—206.
3.
Pawlikowska T. , Chalder T., Hirsch SR, Wallace P., Wright DJ, Wessely SCPopulation based study of fatigue and psychological distress. Br Med J1994;308:763—6.
4.
Chalder T., Berelowitz G., Pawlikowska T., Watts L., Wessely S., Wright D., et al. Development of a fatigue scale. J Psychosom Res1993;372:147—53.
5.
Bultmann U., Kant I., Kasl SV, Beurskens AJ, van den Brandt PAFatigue and psychological distress in the working population. Psychometrics, prevalence, and correlates. J Psychosom Res2002;52:445—52.
6.
Norrelund N., Hollnagel H.Fatigue among 40-year-olds. Ugeskr Laeger1979;141:1425—9.
7.
Sharpe M.The English Chief Medical Officer's Working Parties' report on the management of CFS/ME. J Psychosom Res2002 ;52:437—8.
8.
Miller AE, Morgante LA, Buchwald LY, Nutile SM, Coyle PK, Krupp LB, et al. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis. Neurology1997;48:312—14.
9.
Belza BLComparison of self-reported fatigue in rheumatoid arthritis and controls . J Rheumatol1995;22:639—43.
10.
Servaes P. , Verhagen C., Bleijenberg G.Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer2002;38:27—43.
11.
Breitbart W., McDonald MV, Rosenfeld B., Monkman ND, Passik S.Fatigue in ambulatory AIDS patients. J Pain Symptom Management1998;15:159—67.
12.
Cathebras PJ, Robbins JM, Kirmayer LJ, Hayton BCFatigue in primary care: prevalence, psychiatric comorbidity, illness behavior, and outcome. J Gen Intern Med1992;7:276—86.
13.
Fuhrer R. , Wessely S.The epidemiology of fatigue and depression: a French primary-care study. Psychol Med1995 ;25:895—905.
14.
Hickie IB , Hooker AW, Hadzi-Pavlovic D., Bennett BK, Wilson AJ, Lloyd ARFatigue in selected primary care settings: sociodemographic and psychiatric correlates. Med J Aust1996;164:585—8.
15.
World Health Organization.The ICD-10 classification of mental and behavioural disorders clinical descriptions and diagnostic guidelines. Geneva: World Health Organization, 1992.
16.
Piper BF, Lindsey AM, Dodd MJFatigue mechanisms in cancer patients: developing nursing theory. Oncol Nurs Forum1987;14:17—23.
Krupp LB, LaRocca NG, Muir-Nash J., Steinberg ADThe fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol1989;46:1121—3.
19.
Bakshi R. , Shaikh ZA, Miletich RS, Czarnecki D., Dmochowski J., Henschel K., et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability . Mult Scler2000;6:181—5.
20.
Krupp LB, Coyle PK, Doscher C., Miller A., Cross AH, Jandorf L., et al. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology1995;45:1956—61.
21.
Kroencke DC, Lynch SG, Denney DRFatigue in multiple sclerosis: relationship to depression, disability, and disease pattern. Mult Scler2000;6:131—6.
22.
Lerdal A. , Celius EG, Moum T.Fatigue and its association with sociodemographic variables among multiple sclerosis patients. Mult Scler2003;9:509—14.
Kleinman L., Zodet MW, Hakim Z., Aledort J., Barker C., Chan K., et al. Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual Life Res2000;9:499—508.
25.
Lichstein KL, Means MK, Noe SL, Aguillard RNFatigue and sleep disorders. Behav Res Ther1997;35:733—40.
26.
Omdal R., Mellgren SI, Koldingsnes W., Jacobsen EA, Husby G.Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, anti-phospholipid antibodies, or other disease characteristics . J Rheumatol2002;29:482—6.
27.
Herlofson K., Larsen JPThe influence of fatigue on health-related quality of life in patients with Parkinson's disease. Acta Neurol Scand2003;107:1—6.
28.
LaChapelle DL, Finlayson MAAn evaluation of subjective and objective measures of fatigue in patients with brain injury and healthy controls . Brain Inj1998;12:649—59.
29.
Stone P., Hardy J., Huddart R., A'Hern R, Richards M. Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer2000;36:1134—41.
30.
Taylor RR , Jason LA, Torres A.Fatigue rating scales: an empirical comparison . Psychol Med2000 ;30:849—56.
31.
Roelcke U. , Kappos L., Lechner-Scott J., Brunnschweiler H., Huber S., Ammann W., et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology1997;48:1566—71.
32.
Bakshi R. , Miletich RS, Henschel K., Shaikh ZA, Janardhan V., Wasay M., et al. Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients. Neurology1999;53:1151—3.
33.
Paulhus DLMeasurement and Control of Response Bias. In: Robinson JP, Shaver PR, Wrightsman LS, editors. Measures of personality and social psychological attitudes. New York: Academic Press, 17—60.
34.
Pincus T.Formal educational level — a marker for the importance of behavioral variables in the pathogenesis, morbidity, and mortality of most diseases?J Rheumatol1988 ;15:1457—60.
35.
Lund E., Gram ITResponse rate according to title and length of questionnaire. Scand J Soc Med1998;26: 154—60.
